Cargando…
Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
PURPOSE OF REVIEW: An overview of how the treatment landscape of axial spondyloarthritis (axSpA) has shaped our understanding of the disease. RECENT FINDINGS: Prior to the millennium, non-steroidal anti-inflammatory drugs (NSAIDs) were the only treatment for axSpA, yet only 30% of patients responded...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958165/ https://www.ncbi.nlm.nih.gov/pubmed/36652160 http://dx.doi.org/10.1007/s11926-023-01097-7 |